» Articles » PMID: 32818603

Heparan Sulfate Deficiency Leads to Hypertrophic Chondrocytes by Increasing Bone Morphogenetic Protein Signaling

Overview
Date 2020 Aug 21
PMID 32818603
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Exostosin-1 (EXT1) and EXT2 are the major genetic etiologies of multiple hereditary exostoses and are essential for heparan sulfate (HS) biosynthesis. Previous studies investigating HS in several mouse models of multiple hereditary exostoses have reported that aberrant bone morphogenetic protein (BMP) signaling promotes osteochondroma formation in Ext1-deficient mice. This study examined the mechanism underlying the effects of HS deficiency on BMP/Smad signaling in articular cartilage in a cartilage-specific Ext mouse model.

Method: We generated mice with a conditional Ext1 knockout in cartilage tissue (Ext1-cKO mice) using Prg4-Cre transgenic mice. Structural cartilage alterations were histologically evaluated and phospho-Smad1/5/9 (pSmad1/5/9) expression in mouse chondrocytes was analyzed. The effect of pharmacological intervention of BMP signaling using a specific inhibitor was assessed in the articular cartilage of Ext1-cKO mice.

Results: Hypertrophic chondrocytes were significantly more abundant (P = 0.021) and cartilage thickness was greater in Ext1-cKO mice at 3 months postnatal than in control littermates (P = 0.036 for femur; and P < 0.001 for tibia). However, osteoarthritis did not spontaneously occur before the 1-year follow-up. matrix metalloproteinase (MMP)-13 and adamalysin-like metalloproteinases with thrombospondin motifs(ADAMTS)-5 were upregulated in hypertrophic chondrocytes of transgenic mice. Immunostaining and western blotting revealed that pSmad1/5/9-positive chondrocytes were more abundant in the articular cartilage of Ext1-cKO mice than in control littermates. Furthermore, the BMP inhibitor significantly decreased the number of hypertrophic chondrocytes in Ext1-cKO mice (P = 0.007).

Conclusions: HS deficiency in articular chondrocytes causes chondrocyte hypertrophy, wherein upregulated BMP/Smad signaling partially contributes to this phenotype. HS might play an important role in maintaining the cartilaginous matrix by regulating BMP signaling.

Citing Articles

TMF suppresses chondrocyte hypertrophy in osteoarthritic cartilage by mediating the FOXO3a/BMPER pathway.

Huang J, Ren Q, Jiao L, Niu S, Liu C, Zhou J Exp Ther Med. 2024; 28(1):283.

PMID: 38800044 PMC: 11117099. DOI: 10.3892/etm.2024.12571.


The roles and regulatory mechanisms of TGF-β and BMP signaling in bone and cartilage development, homeostasis and disease.

Wu M, Wu S, Chen W, Li Y Cell Res. 2024; 34(2):101-123.

PMID: 38267638 PMC: 10837209. DOI: 10.1038/s41422-023-00918-9.


Transcriptional profiling of human cartilage endplate cells identifies novel genes and cell clusters underlying degenerated and non-degenerated phenotypes.

Kuchynsky K, Stevens P, Hite A, Xie W, Diop K, Tang S Arthritis Res Ther. 2024; 26(1):12.

PMID: 38173036 PMC: 10763221. DOI: 10.1186/s13075-023-03220-6.


Proteoglycan inhibition of canonical BMP-dependent cartilage maturation delays endochondral ossification.

Koosha E, Brenna C, Ashique A, Jain N, Ovens K, Koike T Development. 2023; 151(2).

PMID: 38117077 PMC: 10820745. DOI: 10.1242/dev.201716.


Disease modification and symptom relief in osteoarthritis using a mutated GCP-2/CXCL6 chemokine.

Caxaria S, Kouvatsos N, Eldridge S, Alvarez-Fallas M, Thorup A, Cici D EMBO Mol Med. 2022; 15(1):e16218.

PMID: 36507558 PMC: 9832835. DOI: 10.15252/emmm.202216218.


References
1.
Stickens D, Zak B, Rougier N, Esko J, Werb Z . Mice deficient in Ext2 lack heparan sulfate and develop exostoses. Development. 2005; 132(22):5055-68. PMC: 2767329. DOI: 10.1242/dev.02088. View

2.
Nakamura R, Nakamura F, Fukunaga S . Disruption of endogenous perlecan function improves differentiation of rat articular chondrocytes in vitro. Anim Sci J. 2014; 86(4):449-58. DOI: 10.1111/asj.12309. View

3.
Nurminskaya M, Linsenmayer T . Identification and characterization of up-regulated genes during chondrocyte hypertrophy. Dev Dyn. 1996; 206(3):260-71. DOI: 10.1002/(SICI)1097-0177(199607)206:3<260::AID-AJA4>3.0.CO;2-G. View

4.
Tchetina E, Kobayashi M, Yasuda T, Meijers T, Pidoux I, Robin Poole A . Chondrocyte hypertrophy can be induced by a cryptic sequence of type II collagen and is accompanied by the induction of MMP-13 and collagenase activity: implications for development and arthritis. Matrix Biol. 2007; 26(4):247-58. DOI: 10.1016/j.matbio.2007.01.006. View

5.
Pesesse L, Sanchez C, Delcour J, Bellahcene A, Baudouin C, Msika P . Consequences of chondrocyte hypertrophy on osteoarthritic cartilage: potential effect on angiogenesis. Osteoarthritis Cartilage. 2013; 21(12):1913-23. DOI: 10.1016/j.joca.2013.08.018. View